Moderna
MRNA
#1696
Rank
ยฃ9.03 B
Marketcap
ยฃ23.11
Share price
-4.73%
Change (1 day)
-27.56%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ50.54 M-67.66%
2024ยฃ0.15 B15.08%
2023ยฃ0.13 B-50.15%
2022ยฃ0.27 B-85.7%
2021ยฃ1.90 B158.2%
2020ยฃ0.73 B369.18%
2019ยฃ0.15 B1011.49%
2018ยฃ14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Regulus Therapeutics
RGLS
N/Aยฃ5.58 M๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ17.08 Mยฃ0.16 B๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.09 Mยฃ0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ8.65 Mยฃ41.99 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ19.76 Mยฃ75.6 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
ยฃ2.01 Mยฃ7.3 M๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ57.52 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA